
DermNexus 2026 experts explored systemic inflammation, skin-gut connections, cancer risk, and multidisciplinary care in dermatologic disease.
The vaccine combines NY-ESO-1 with IMX, a potent immune-system stimulator that consists of cholesterol, phospholipids and saponin.






